One out of 3 Indian females suffers from osteoporosis, making India one of the most affected countries in the world, according to the International Osteoporosis Foundation. Additionally, in most Western countries, the peak incidence of osteoporosis occurs at about 70 to 80 years of age; in India, it occurs 10…
Read more »
Metabolic syndrome is a known risk factor for cardiovascular disease, diabetes, and cancer. The diagnosis is made based on the presence of 3 or more of the following clinical signs: waist circumference of 88 cm or more; serum triglycerides of 1.7 mmol/L or more; blood pressure of 130/85 mmHg or…
Read more »
Postmenopausal women with type 2 diabetes that requires treatment with insulin demonstrated an increased risk for developing lung cancer, according to an analysis of the Women’s Health Initiative (WHI) study. “Physicians in India should screen diabetes patients, especially women, for lung cancer, particularly those on insulin therapy.” -Vijay Viswanathan, MD,…
Read more »
Postmenopausal women with type 2 diabetes demonstrated an increased risk for cancers of the liver, pancreas, colon, and rectum, according to an analysis of the Women’s Health Initiative (WHI) study. It was estimated that 41 million people in India had type 2 diabetes in 2006, according to a 2010 report…
Read more »
Calcium supplements are commonly recommended to the elderly and post-menopausal women for optimal maintenance of bone health. Previous research has reported that a higher calcium intake may lead to a decrease in risk factors for myocardial infarction (MI) and stroke, including hypertension, type 2 diabetes, and obesity. “In a country…
Read more »
The presence of metabolic syndrome is associated with all-cause mortality in women aged 70 to 79 years, while no significant risk was found in similarly aged men. This was the finding of a recent cohort study that sought to determine the association of metabolic syndrome with all-cause mortality in older…
Read more »
indicates a Peer-Reviewed Article
Long-term bisphosphonate therapy of unproven benefit in fracture prevention
The benefit of bisphosphonates beyond 3 years in preventing fracture is unproven, according to a recent systematic review of the clinical data. The number of people in India with osteoporosis is expected to hit 36 million by 2013, according to a 2012 article in the Journal of Family Medicine and…
Read more »